Webinar: Drug Delivery — Evaluating Off The Shelf and Novel Drug Delivery Solutions

During this session, featured speaker Brandon Bogdalek, will interview three industry leading panelists. The panelists will discuss important factors to consider when evaluating off-the-shelf (OTS) drug delivery platforms vs. developing a novel solution. Key topics will include cost and pricing impacts, timeline to commercialization, as well as R&D, human factors and user needs considerations. Panelists will share their perspectives with respect to choosing OTS solutions or building a novel drug delivery platform.

Discover the factors to consider when evaluating off-the-shelf (OTS) vs. novel drug delivery solutions.

 

ICER Set to Evaluate Non-Drug Products in 2020

The Boston-based Institute for Clinical and Economic Review (ICER), an independent research organization that conducts health technology assessments...

Read More